In 2024, Brilitas Pharmaceuticals EU OÜ had revenue of 24 thousand EUR and profit of 14.9 thousand EUR. Beneficial owners: Quang Dăng Tran.
| year | 2024Latest | 2023 |
|---|---|---|
Revenue | 24k € | 0 € |
Profit | 14,9k € +1123.7% | -1,5k € |
Assets | - | - |
Liabilities | - | - |
Equity | 34,3k € +2466.6% | -1,5k € |
Employees | - | - |
Overall rating | A85/100 |
Financial health | 100/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Low |
No risk flags | |
Possible tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - |
Brilitas Pharmaceuticals EU OÜ is located at Harju maakond, Tallinn, Kesklinna linnaosa, Pärnu mnt 110, 11313.
In 2024, Brilitas Pharmaceuticals EU OÜ had revenue of 24 000 EUR and profit of 14 854 EUR. View full financial report →
The beneficial owners of Brilitas Pharmaceuticals EU OÜ are Quang Dăng Tran. View ownership details →
No, Brilitas Pharmaceuticals EU OÜ does not have an active VAT number and is not registered as a VAT payer.
Brilitas Pharmaceuticals EU OÜ was founded on November 22, 2022. The company has been operating for 4 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 4 years | 1628 - 1632 | 22% | |
Net revenue | 24 000,00 € | 905 - 909 | 57% | |
Profit | 14 854,00 € | 456 - 460 | 78% | |
Equity | 34 339,00 € | 673 - 677 | 65% | |
Profitability | 61.9% | - | 90% | |
Registered capital | 65 000,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Registered in the Estonian business register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| Quang Dăng Tran | - | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Quang Dăng Tran | EE | - |